Showing results (141-150 of 345) with videos related to

Sort By:
Pageof 35
The Journal of Clinical Endocrinology and Metabolism|February 7, 2001
Blockade of the growth hormone (GH) receptor unmasks rapid GH-releasing peptide-6-mediated tissue-specific insulin resistanceA F Muller, J A Janssen, L J Hofland, et al.
The Journal of Clinical Endocrinology and Metabolism|May 18, 2026
Heterogeneity of MGMT expression in corticotroph adenomas and mechanism of acquired temozolomide resistanceTiciana Paes, Richard A Feelders, Fadime Dogan, et al.
International Journal of Cancer|May 4, 1999
Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapyW A Breeman, L J Hofland, M de Jong, et al.
British Journal of Cancer|November 8, 2006
The role of superoxide anions in the development of distant tumour recurrenceM ten Kate, J B C van der Wal, W Sluiter, et al.
The Journal of Clinical Endocrinology and Metabolism|January 9, 2013
Circulating IgGs may modulate IGF-I receptor stimulating activity in a subset of patients with Graves' ophthalmopathyAimee J Varewijck, Anita Boelen, Steven W J Lamberts, et al.
BMC Cancer|September 24, 2020
Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancerAmber Blaauboer, Stephanie Booy, Peter M van Koetsveld, et al.
Endocrinology, Diabetes & Metabolism Case Reports|April 21, 2018
Successful neoadjuvant peptide receptor radionuclide therapy for an inoperable pancreatic neuroendocrine tumourTiago Nunes da Silva, M L F van Velthuysen, Casper H J van Eijck, et al.
International Journal of Cancer|December 17, 1997
Paracrine interactions between mesothelial and colon-carcinoma cells in a rat modelB C van der Wal, L J Hofland, R L Marquet, et al.
Endocrine-Related Cancer|October 18, 2015
Future directions in the diagnosis and medical treatment of adrenocortical carcinomaS G Creemers, L J Hofland, E Korpershoek, et al.
Pageof 35